Literature DB >> 35416965

Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

William M Geisler1, Jane S Hocking2, Toni Darville3, Byron E Batteiger4, Robert C Brunham5.   

Abstract

To prepare for the development of the 2021 Centers for Disease Control and Prevention (CDC) sexually transmitted infections treatment guidelines, the CDC convened a committee of expert consultants in June 2019 to discuss recent abstracts and published literature on the epidemiology, diagnosis, and management of sexually transmitted infections.This paper summarizes the key questions, evidence, and recommendations for the diagnosis and management of uncomplicated Chlamydia trachomatis (CT) infections in adolescents and adults that were reviewed and discussed for consideration in developing the guidelines. The evidence reviewed mostly focused on efficacy of doxycycline and azithromycin for urogenital, rectal, and oropharyngeal CT infection, CT risk factors in women, performance of CT nucleic acid amplification tests on self-collected meatal specimens in men, and performance of newer CT point-of-care tests.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CDC; chlamydia; diagnosis; guidelines; management; screening; treatment

Mesh:

Substances:

Year:  2022        PMID: 35416965      PMCID: PMC9006972          DOI: 10.1093/cid/ciac126

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  80 in total

Review 1.  The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis.

Authors:  Fabian Yuh Shiong Kong; Sepehr N Tabrizi; Christopher Kincaid Fairley; Lenka A Vodstrcil; Wilhelmina M Huston; Marcus Chen; Catriona Bradshaw; Jane S Hocking
Journal:  J Antimicrob Chemother       Date:  2015-01-29       Impact factor: 5.790

2.  Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.

Authors:  K Manavi; N Hettiarachchi; J Hodson
Journal:  Int J STD AIDS       Date:  2015-10-27       Impact factor: 1.359

3.  Comparison of the Cepheid GeneXpert CT/NG assay to the Hologic Aptima Combo2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in self-collected rectal swabs.

Authors:  Laura Dize; Barbara Silver; Charlotte Gaydos
Journal:  Diagn Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 2.803

4.  Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population.

Authors:  Delia Scholes; Catherine L Satterwhite; Onchee Yu; David Fine; Hillard Weinstock; Stuart Berman
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

5.  A Population-Based Study to Compare Treatment Outcomes Among Women With Urogenital Chlamydial Infection in Washington State, 1992 to 2015.

Authors:  Christine M Khosropour; Teal R Bell; James P Hughes; Lisa E Manhart; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2018-05       Impact factor: 2.830

6.  Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women.

Authors:  William M Geisler; Maria Luz G Pascual; Judy Mathew; William D Koltun; Franklin Morgan; Byron E Batteiger; Annette Mayes; Sijia Tao; Selwyn J Hurwitz; Chalom Sayada; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

7.  A recommendation for timing of repeat Chlamydia trachomatis test following infection and treatment in pregnant and nonpregnant women.

Authors:  Gweneth B Lazenby; Jeffrey E Korte; Sarah Tillman; Florence K Brown; David E Soper
Journal:  Int J STD AIDS       Date:  2016-11-18       Impact factor: 1.359

8.  Comparative Evaluation of 2 Nucleic Acid Amplification Tests for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae at Extragenital Sites.

Authors:  Claire C Bristow; Mark R McGrath; Adam C Cohen; Laura J Anderson; Kristie K Gordon; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-07       Impact factor: 2.830

9.  Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study.

Authors:  Christine M Khosropour; Lisa E Manhart; Danny V Colombara; Catherine W Gillespie; M Sylvan Lowens; Patricia A Totten; Matthew R Golden; Jane Simoni
Journal:  Sex Transm Infect       Date:  2013-10-08       Impact factor: 3.519

10.  Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.

Authors:  E M Harding-Esch; S S Fuller; S-L C Chow; A V Nori; M A Harrison; M Parker; O Piepenburg; M S Forrest; D G Brooks; R Patel; P E Hay; N Fearnley; M J Pond; J K Dunbar; P D Butcher; T Planche; C M Lowndes; S T Sadiq
Journal:  Clin Microbiol Infect       Date:  2018-06-12       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.